LivaNova PLC logo

LivaNova PLC

1
NAS:LIVN (UK)  
$ 61.05 +0.24 (+0.39%) 10:08 PM EST
At Loss
P/B:
2.71
Volume:
194.85K
Avg Vol (2M):
593.01K
Also Trade In:
Volume:
194.85K
At Loss
Avg Vol (2M):
593.01K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for LIVN ( LivaNova PLC ) from 1993 to Jun 02 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. LivaNova PLC stock (LIVN) PE ratio as of Jun 02 2024 is 0. More Details

LivaNova PLC (LIVN) PE Ratio (TTM) Chart

To

LivaNova PLC (LIVN) PE Ratio (TTM) Historical Data

Total 1241
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
LivaNova PLC PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-03 At Loss 2024-03-28 At Loss
2024-05-31 At Loss 2024-03-27 174.6
2024-05-30 At Loss 2024-03-26 170.0
2024-05-29 At Loss 2024-03-25 170.1
2024-05-28 At Loss 2024-03-22 174.9
2024-05-24 At Loss 2024-03-21 175.9
2024-05-23 At Loss 2024-03-20 177.0
2024-05-22 At Loss 2024-03-19 157.3
2024-05-21 At Loss 2024-03-18 158.6
2024-05-20 At Loss 2024-03-15 158.1
2024-05-17 At Loss 2024-03-14 159.8
2024-05-16 At Loss 2024-03-13 163.4
2024-05-15 At Loss 2024-03-12 162.4
2024-05-14 At Loss 2024-03-11 164.4
2024-05-13 At Loss 2024-03-08 167.9
2024-05-10 At Loss 2024-03-07 168.6
2024-05-09 At Loss 2024-03-06 166.4
2024-05-08 At Loss 2024-03-05 163.7
2024-05-07 At Loss 2024-03-04 174.5
2024-05-06 At Loss 2024-03-01 172.6
2024-05-03 At Loss 2024-02-29 171.3
2024-05-02 At Loss 2024-02-28 172.2
2024-05-01 At Loss 2024-02-27 174.7
2024-04-30 At Loss 2024-02-26 174.9
2024-04-29 At Loss 2024-02-23 178.5
2024-04-26 At Loss 2024-02-22 175.8
2024-04-25 At Loss 2024-02-21 177.6
2024-04-24 At Loss 2024-02-20 164.4
2024-04-23 At Loss 2024-02-16 155.9
2024-04-22 At Loss 2024-02-15 156.4
2024-04-19 At Loss 2024-02-14 152.3
2024-04-18 At Loss 2024-02-13 152.8
2024-04-17 At Loss 2024-02-12 158.4
2024-04-16 At Loss 2024-02-09 157.9
2024-04-15 At Loss 2024-02-08 158.5
2024-04-12 At Loss 2024-02-07 154.7
2024-04-11 At Loss 2024-02-06 156.0
2024-04-10 At Loss 2024-02-05 151.9
2024-04-09 At Loss 2024-02-02 153.0
2024-04-08 At Loss 2024-02-01 154.5
2024-04-05 At Loss 2024-01-31 152.1
2024-04-04 At Loss 2024-01-30 155.5
2024-04-03 At Loss 2024-01-29 157.7
2024-04-02 At Loss 2024-01-26 154.8
2024-04-01 At Loss 2024-01-25 156.1

LivaNova PLC (LIVN) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

LivaNova PLC logo
LivaNova PLC
NAICS : 339112 SIC : 3842
ISIN : GB00BYMT0J19
Description
UK-based LivaNova was born of a combination between Cyberonics in the us and Sorin in Italy. The medical-device firm is primarily focused on cardiovascular and cardiopulmonary solutions (with surgical heart valves, heart-lung machines, and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management and heart valve businesses. It derives roughly half of its revenue from the us market, another 21% from Europe, and the remainder from the rest of the world.